Biondo Investment Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-113,634
Closed -$8.66M 92
2023
Q4
$8.66M Sell
113,634
-1,075
-0.9% -$82K 1.47% 25
2023
Q3
$7.95M Buy
114,709
+83
+0.1% +$5.75K 1.5% 24
2023
Q2
$10.8M Sell
114,626
-1,782
-2% -$168K 2% 15
2023
Q1
$9.63M Buy
116,408
+469
+0.4% +$38.8K 1.95% 19
2022
Q4
$8.65M Buy
115,939
+282
+0.2% +$21K 1.93% 20
2022
Q3
$9.56M Buy
115,657
+93
+0.1% +$7.69K 2.2% 13
2022
Q2
$11M Sell
115,564
-3,694
-3% -$351K 2.42% 11
2022
Q1
$14M Sell
119,258
-225
-0.2% -$26.5K 2.47% 10
2021
Q4
$15.5M Sell
119,483
-3,615
-3% -$468K 2.58% 10
2021
Q3
$13.9M Buy
123,098
+1,105
+0.9% +$125K 2.39% 12
2021
Q2
$12.6M Sell
121,993
-239
-0.2% -$24.8K 2.17% 15
2021
Q1
$10.2M Sell
122,232
-6,879
-5% -$575K 2.04% 16
2020
Q4
$11.8M Buy
129,111
+1,670
+1% +$152K 2.26% 13
2020
Q3
$10.2M Buy
127,441
+49,690
+64% +$3.97M 2.21% 11
2020
Q2
$5.37M Buy
77,751
+8,880
+13% +$614K 1.36% 23
2020
Q1
$4.33M Buy
68,871
+45,036
+189% +$2.83M 1.43% 28
2019
Q4
$1.85M Buy
23,835
+7,755
+48% +$603K 0.43% 43
2019
Q3
$1.18M Buy
16,080
+5,310
+49% +$389K 0.3% 49
2019
Q2
$663K Buy
10,770
+120
+1% +$7.39K 0.16% 64
2019
Q1
$679K Buy
10,650
+5,250
+97% +$335K 0.17% 53
2018
Q4
$276K Buy
5,400
+225
+4% +$11.5K 0.08% 76
2018
Q3
$300K Buy
5,175
+150
+3% +$8.7K 0.07% 76
2018
Q2
$244K Hold
5,025
0.06% 78
2018
Q1
$234K Buy
+5,025
New +$234K 0.06% 86
2014
Q1
Sell
-60,000
Closed -$658K 94
2013
Q4
$658K Sell
60,000
-72,888
-55% -$799K 0.22% 64
2013
Q3
$1.54M Buy
132,888
+4,710
+4% +$54.7K 0.59% 38
2013
Q2
$1.44M Buy
+128,178
New +$1.44M 0.62% 41